San Diego, October 19, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States to launch the world’s first cannabis-derived products, brands and supply chain, today announced that its subsidiary Kannawi® Peter J.E. Verdigim, PhD, MSc, and MBA has been appointed as the company’s vice president for North America and German-speaking countries and product development.
“In addition to his experience successfully launching direct selling operations across North America, Asia and Latin America, we are excited by Peter’s shared passion for driving positive global change through health and wellness,” said Blake Schroeder, CEO of Kannaway. “Peter will lead domestic and international expansion efforts, particularly in North America and countries where German is the primary language, and will lead the company’s product development initiatives.”
Peter Verdegem is a seasoned leader in direct sales with over twenty years of experience. He has held executive positions at some of the largest and most successful direct selling companies in the world. Verdegem has managed teams in areas such as product development, training, sales and marketing, and international operations. Throughout his career, he has developed a keen interest and focus on nutrition and wellness products, making his new role with Kannaway® a natural and strategic fit. Peter holds an MBA from Brigham Young University and a Ph.D. in Organic Biochemistry and an MA in Organic Chemistry from Leiden University in the Netherlands.
“I believe in the business opportunity that direct sales presents to people of all backgrounds around the world, and I look forward to continuing to drive the industry forward with Kannaway,” said Peter JE Verdegem, Vice President of Kannaway® in North America and German Speaking Countries. Product development. “according to Grand View ResearchThe global CBD market is expected to be worth $13.4 billion by 2028. This kind of growth excites me, and I believe Kannaway has the professionalism and talent needed to dominate this industry. “
To learn more about Kannaway®, please visit the website https://kannaway.com/.
Kannawi® is a network sales and marketing company specializing in the sale and marketing of plant based cannabis products. Currently, Kannaway® hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity for sales professionals who wish to become successful leaders in the sale and marketing of plant-based, hemp-based products.
About Medical Marijuana, Inc.
We are Firsts® شركة. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabis space: a global group of cannabis-based food brands led by Kannawi® And HempMeds®; A leader in sourcing high-quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the sector of cannabis-based clinical research and development of botanical medicines led by pharmaceutical investment companies and their partners including AXIM® BiotechnologyAnd a company. And Neuropathics. Medical Marijuana, Inc. As the best CBD product ever CNBC. Medical Marijuana, Inc. Also the first company to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a pioneer in developing international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To watch a video of Medical Marijuana, Inc. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor law created by those sections. This material contains statements about expected future events and/or financial results of a forward-looking nature and subject to risks and uncertainties. These forward-looking statements by definition include risks, uncertainties and other factors, which could cause Medical Marijuana, Inc.’s actual results, performance or achievements to differ. materially from the data contained herein.
Disclosure by the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not. Selling or distributing any products that violate the Controlled Substances Act in the United States.
Investor Relations Contact:
p. (858) 283-4016